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Abstract 
 Pax5 is the master regulator of B-cell development.  Pax5 is highly conserved 
between invertebrate and vertebrate species and is known to be alternatively spliced.  An 
isoform missing exon 2 appears to be species independent.  This is significant because 
exon 2 contains the DNA binding domain and thus these isoforms have decreased DNA 
binding, which change their function as a transcription factor.  This project aimed to 
determine if there are changes in the alternative splicing of Pax5 during a humoral 
immune response in spawning sockeye salmon (Onchorynchus nerka).  Specifically, this 
project looked at the changes in Onchorynchus Pax5 isoforms that lack exon 2, to 
determine if these changes correlated with an increase in the amount of secreted IgM in 
such animals.  Real-time PCR was performed using primers that amplified full length 
Pax5, the Pax5Δ2 isoform, and secreted and membrane IgM.  The relative expression 
levels of Pax5Δ2/Pax5FL were then compared to the relative expression levels of 
secreted/membrane IgM.  This project concluded that there is a positive correlation 
between the levels of secreted IgM and Pax5Δ2.  This positive correlation was observed 
in vivo in O. mykiss in the laboratory, in vitro in LPS activated B-cells from O. mykiss, 
and in vivo in spawning O. nerka samples for spleen and blood.  This conclusion supports 
the model that Pax5Δ2 is acting as a co-repressor of Pax5FL by binding to the initiation 
complex on the Xbp1 gene, thus changing the shape of the initiation complex and 
preventing Pax5FL from binding to the promoter region of the Xbp1 gene.   
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Introduction 
 The immune system is a highly adaptable system that has evolved to protect 
organisms from pathogens.  To adequately protect against pathogens, the system must be 
able to both recognize and respond to foreign invaders.  In vertebrates, there are two 
systems of immunity.  Innate immunity is the highly effective first line of defense, which 
includes molecular and cellular mechanisms that are poised and ready to prevent and 
eliminate infection.  In contrast, adaptive immunity develops in response to an infection 
and adapts to recognize, eliminate, and remember the foreign invader.  Collaboration 
between the innate and adaptive immune responses increases the effectiveness of an 
immune response.  This thesis focuses on the adaptive immune system in fish.  The 
following briefly reviews the adaptive immune system in the well-characterized 
mammalian species, mouse and humans. 
The Adaptive Immune System in Mammals. 
 The main players in adaptive immune responses are the lymphocytes.  
Lymphocytes are a type of white blood cell produced in the bone marrow.  Upon leaving 
the bone marrow, lymphocytes circulate in the blood and lymphatic system and reside in 
various lymphoid organs.  The two major populations of lymphocytes are B lymphocytes 
(B cells) and T lymphocytes (T cells).  This work focuses on B cells.  B cells are the main 
players in humoral immunity (B cell response), and produce antibody or 
immunoglobulin.  This “humoral” immune response protects against extracellular 
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bacteria, viruses, and foreign macromolecules through the binding of immunoglobulin, 
present in the plasma, lymph and tissue fluids.   
 After maturing in the bone marrow, B cells express unique antigen-binding 
receptors on their membrane, known as “membrane-bound” immunoglobulins.  When an 
antigen binds to “membrane-bound” immunoglobulins, it causes the cell to divide.  The 
progeny differentiate into memory B cells and effector B cells (plasma cells).  Memory B 
cells have a long life span and are prepared for another encounter with the same antigen.  
The majority of plasma cells only have a short half-life, but are able to produce very high 
quantities of a secreted form of antibody or immunoglobulin in that time.  These secreted 
antibodies are the major effector molecules of humoral immunity (Kuby).  A small 
population of so-called long-lived plasma cells will move to the bone marrow and may 
keep secreting antibodies for many years (Elliyard et al. 2004 and Bromage et al. 2004). 
 In mammalian species, immunoglobulins are composed of four peptide chains, 
two identical light chains, and two identical heavy chains.  Mammalian species have five 
different heavy chain constant regions, µ, γ, ϵ, α, and δ.  The heavy chains of the 
immunoglobulin determine the class of the antibody: IgM (µ), IgG (γ), IgA (α), IgD (δ), 
IgE (ϵ).  The five classes of immunoglobulin can be expressed either as secreted or 
membrane immunoglobulin.  The carboxyl-terminal domain in secreted immunoglobulin 
is both structurally and functionally different from the corresponding domain in 
membrane-bound immunoglobulin.   Immunoglobulins bind to antigen, which invokes a 
number of responses that result in the removal of the antigen and death of the pathogen.  
This honors research used the ratio of secreted/membrane IgM as a marker of immune 
response. The membrane bound µ heavy chain is expressed on mature, resting B cells.  In 
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contrast, plasma cells lack membrane IgM but make high levels of secreted IgM.  Hence, 
the more activated a cell, the higher the ratio of secreted IgM/ membrane IgM becomes. 
 
Figure 1: A resting, mature B-cell upon activation, becomes activated, then becomes a 
plasmablast, and finally, a plasma cell.  The amount of membrane IgM decreases during 
this process, while the amount of secreted IgM increases. (from Zwollo, 2011). 
The Teleost Model 
 Our lab uses teleost fish as a model organism to study the immune system.  It is 
important to study the teleost clade for a number of reasons.  The appearance of the jaw 
in evolutionary history is coordinated with the development of an adaptive immune 
system, thus teleosts represent one of the earliest clades to have this system (Matsunaga 
and Rahman, 1998).  The lymphocytes of teleost fish are highly diverse, similar to what 
is seen in humans.  Thus, a study of the B-lymphocytes in teleost fish could bring us one-
step closer to answering vital questions related to disease in human populations.  
Additionally, the farming of teleost fish is a source of food worldwide.  These 
populations of farmed fish are susceptible to a number of diseases.  Basic prevention in 
the form of sanitation, chemical treatment of the water, and antibiotics in food are helping 
to limit the loss of fish currently.  Studies on the immune system of fish could further the 
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development of both preventative measures and treatment options for these diseases, thus 
keeping the animals healthy (Food and Ag. Organization of the United Nations). 
 Previous studies have begun to dissect the immune system of teleost species, 
specifically the rainbow trout.  Teleosts are an interesting model for immunology 
research because these organisms do not possess bone marrow or lymph nodes.  In 
teleosts, the major immune organs are the kidney, spleen and blood.  The anterior kidney 
is the main site of hematopoesis in the teleost (Zwollo et al., 2005, 2010, Zapata and 
Cooper, 1990, and Katarri and Irwin, 1985).  Additionally, research has shown that there 
is a B-cell maturation gradient along the teleost kidney: the anterior kidney is home to 
(mostly proliferating) B cell precursors and long-lived plasma cells while the posterior 
kidney is home to partially activated B-cells as well as plasmablasts (Zwollo et al., 2005).  
The blood lacks plasma cells and contains mostly resting cells (Zwollo et al., 2005, 
2008).  In vitro lipopolysaccharide (LPS) induction of mature B-cells causes splenic cells 
to progress from plasmablast to the plasma cell stage, while B-cells in the blood do not 
generate plasma cells and generate much fewer plasmablasts.  Thus, B-cell populations 
vary significantly between the blood, spleen, posterior kidney and anterior kidney.  Based 
on these data, previous research has indicated the anterior kidney as a primary immune 
organ in teleosts while the posterior kidney and spleen function as secondary immune 
organs.  Additionally, the blood has been characterized as a reservoir to store and 
transport B-cells. Figure 2 summarizes the types of B-cells found in each immune tissue 
in teleosts (Zwollo et al, 2005).   
 In land vertebrates, there are several Ig classes with differing structure and 
function produced by B-cells.  In fish, immunoglobulins are of lower affinity and there 
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are only three classes of Ig, with the main type corresponding to mammalian IgM.  IgM is 
a pentamer with ten binding sites in most vertebrate species, but in fish it is composed of 
four basic units with eight binding sites, the lack of two binding sites is thought to be 
responsible for less efficient Ig binding in teleost fish (Pilstrum and Bengten, 1996).  In 
addition to IgM, teleost B-cells have very low percentage of IgT and IgD.  Interestingly, 
in fish, there appears to only be one gene for the IgM, but the gene for the IgD and IgT 
has been duplicated, possibly due to the tetraploid ancestry of salmonoid fish (Hansen et 
al., 2005). 
 
Figure 2: Model showing the stage of B cell development and activation cells in each of 
the immune organs of the teleost. (Zwollo et al. 2005).  This model illustrates the 
maturation gradient.  B cell activation occurs in the Posterior Kidney as well as the 
Spleen.  According to this model, once cells have matured all of the way to the plasma 
cell stage, they can travel back into the anterior kidney and survive as long-lived plasma 
cells.  
 Transcription factor structure and function is conserved between species due to 
the highly conserved nature of DNA binding domains.  Therefore, using transcription 
factors as developmental markers in species such as teleosts, which are much less well-
studied than mammalian species, allows researchers to take a comparative approach to 
the study of gene regulation.  Trout Pax5 protein has 79% homology with mouse Pax5 
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indicating that it is functionally relatively similar to its mammalian homolog.  More 
importantly, the paired domain, or DNA binding domain, of transcription factors is the 
most highly conserved domain of the Pax5 protein, with homology as high as 95-99% 
(Zwollo, 2011).  The ability to use antibodies to mammalian homologs of the gene 
highlights the importance of this comparative approach (reviewed in Zwollo et al, 2011). 
Pax5 is a Regulator of B-cell Development 
 Pax5 is a transcription factor found in vertebrate B cells and adult testis as well as 
in the midbrain of developing embryos.  This research focused on the Pax5 gene in 
teleost B-cells.  Studies in mammals have shown that the differentiation of hematopoietic 
stem cells (HSC) into B-cells is a process that must be controlled by a number of 
transcription factors that aid in lineage specification as well as lineage commitment 
(Pridans et al., 2008).  The transcription factor Pax5 is implicated in the commitment of 
lymphoid progenitors to the B-cell lineage.  The Pax5 gene encodes the B-cell-specific 
activator protein (BSAP).  Pax5 is first expressed in the B-cell lineage at the pro-B cell 
stage, remains highly expressed in the mature B-cells, and is repressed during plasma cell 
differentiation.  In order for a B-cell to develop normally, Pax5 must be constitutively 
expressed.  Previous research indicates that Pax5 inactivation can cause mature B cells to 
convert into T cells via dedifferentiation into uncommitted progenitors.  Thus, Pax5 is 
considered the “guardian” of both the identity and function of B-lymphocytes (Cobaleda 
et al., 2007).   
 Research suggests that the stepwise activation of Pax5 in early lymphopoiesis 
may provide insights into the process of B cell commitment.  Many additional factors are 
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implicated in regulating the Pax5 gene including PU.1, IRG4, IRF8, and NF-κB, Blimp-1 
and Xbp-1.  Additionally, researchers have proposed a role for EBF1 in inducing 
chromatin accessibility in the Pax5 promoter region (Decker et al, 2009).  Of the factors 
regulating Pax5 during terminal B-cell differentiation, the two most important ones are 
Blimp-1 and Xbp-1.  During B-cell activation, the induction of Blimp-1 causes the 
reduction in Pax5 levels.  Blimp-1 also causes immunoglobulin expression to shift from 
the membrane to secreted form, leading to increased levels of secreted immunoglobulin 
and decreased levels of membrane bound immunoglobulin. Xbp-1 expression is repressed 
in mature, resting B cells, but is de-repressed as a result of Pax5 down-regulation by 
Blimp-1.  Xbp-1, along with Blimp-1, is necessary to drive B-cells toward the plasma cell 
stage.  An important marker for B-cell activation is the ratio of secreted to membrane 
immunoglobulin because this ratio is very low in mature B cells and is increased 
significantly in activated B-cells and plasmablasts.  Plasma cells lack membrane bound 
immunoglobulin altogether and have the highest ratio of secreted to membrane IgM.  In 
rainbow trout, the transcription factors EBF, Pax5, Ikaus, Blimp1, and XbpI, have been 
identified as well, and likely play similar roles in B cell development and activation 
(reviewed in Zwollo et al., 2011).  
The structure of Pax5 is important in determining protein function. 
 In biology, structure is closely related to function.  The Pax5 gene is 190-kb-long 
and is transcribed from two separate promoters (Figure 3).  This gives rise to two distinct 
mRNAs by alternative splicing of exon 1 at the 5′ end of the gene (1A and 1B) onto the 
common coding sequences of exons 2–10 (Busslinger et al. 1996).  The full-length 
vertebrate Pax5 protein is 391 amino acids in size (Adams et al., 1992).  Pax proteins 
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bind to target genes via the paired domain, the only DNA binding domain in Pax5.  The 
paired domain of the Pax5 gene is encoded by exons 2 and 3, and spans 128 amino acids 
(Chi and Epstein, 2002).   
 
  
Figure 3: The structure of the full-length Pax5 gene.  The transactivation domain is 
found in exon 9 and exon 10 while the paired domain is found in exon 2 and exon 3.  
There are two start sites in this gene, one in exon one and a second in exon 3 (Zwollo et 
al., 1997).  
 
Alternative splicing allows one gene to function in diverse ways. 
 Alternative splicing is the splicing of the same pre-mRNA two or more ways 
which allows one gene to encode for two or more different mRNAs, which in turn leads 
to two or more protein products.  Previous research has found that the Pax5 gene is 
alternatively spliced during B-cell development in mouse and humans (Zwollo et al., 
1997).  The first research in the area of Pax5 alternative splicing discovered the presence 
of Pax5 isoforms Pax-5a, Pax-5b, Pax-5d, and Pax-5e in mice.  Pax-5a is the full-length 
isoform while Pax-5b and Pax-5e have their second exon spliced out.  Isoforms lacking 
exon 2 will be referred to as Pax5Δ2 (Figure 4). 
 In mice, Pax5Δ2 protein is undetectable in pro-B-cells but becomes detectable 
during later stages of B-cell development and therefore has been stated to correlate with 
the differentiation stage of B-cell lines (Zwollo et al. 1997).  Based on this expression 
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pattern, Pax5Δ2 has been hypothesized to play a regulatory role in transcription. When 
exon 2 is spliced out, the resulting mRNA only contains 214 nucleotides from exon 3. 
The transcripts lacking exon 2 use the second AUG for translation, due to a stop codon in 
exon 3, and as a result, only a very small part of the DNA binding domain remains in 
delta2 Pax5 proteins.  Not surprisingly, previous research has shown that Pax5Δ2 does 
not bind to DNA in vitro (Zwollo et al. 1997). 
 In addition to having a partial DNA-binding domain, exon 2–lacking isoform Pax-
5e has also deleted the 3’ region which contains the transactivation domain and replaced 
it with a novel sequence.  This splicing changes the transcription factor’s ability to bind 
to target DNA and thus its ability to alter gene expression.  Pax-5a is expressed in pro-, 
pre- and mature B-cell lines while Pax-5b is present at low levels in mature B-cell lines 
but not in pro-B or T-cell lines.  Pax-5a and Pax-5d are able to interact with a protein 
binding site on the blk promoter.  This gene encodes a protein tyrosine kinase that 
associates with the B-cell antigen receptor complex and expression is restricted to B-
lymphoid cells. Pax-5b and Pax-5e could not bind to the promoter.  From this study, 
researchers concluded that differential expression of alternatively spliced Pax-5 isoforms 
could be integral regulators of transcription during B-cell development (Zwollo et al., 
1997).  
 The Pax5Δ2 isoform may be able to interact with other regulatory proteins, even 
though it cannot bind to the BSAP site, and could function as a co-repressor by 
competing with Pax5FL for binding to regulatory molecules.  Alternatively, Pax5Δ2 
could be a co-activator through interaction with other transcription factors (Zwollo et al., 
1997). 
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Figure 4: Structure of the Pax5Δ2 isoform.  Note that Exon 2, missing in this isoform, is 
a component of the Paired Box domain of the Pax5 gene (Zwollo).  The resulting protein 
is shorter as it starts at AUG2 (see figure 3). 
 Studies conducted at the Atlantic Cancer Research Institute state that in normal, 
human B cells, there are multiple isoforms of Pax5, including isoforms lacking exon 2, as 
well as in B-cell lymphoma and chronic lymphoid lymphoma cells.  These isoforms were 
not deregulated, but instead showed complex patterns of expression (Arseneau et al., 
2009).  It has been observed that multiple myeloma patients have higher Blimp1 levels 
and lower levels of Pax5 compared to healthy donors, which suggests that the mature B 
cells in these patients are in a more activated state (Borston et al., 2002).  Increased levels 
of alternative splice forms are also seen in these patients.  Thus, abnormal expression of 
alternative Pax5 splice forms may cause resting B-cells to go into an activated state by 
preventing repression of Blimp1 (Borston, et al., 2002). 
 Our lab discovered recently that the rainbow trout Pax5 gene is also extensively 
alternatively spliced, including isoforms lacking exon 2 (unpublished results).  This 
honors thesis research aimed to investigate the expression of Pax5Δ2 in B-cells of LPS 
activated rainbow trout B cells, and in B cells of spawning Oncorhynchus nerka (O. 
nerka).   
Spawning and Immunity in Salmon 
 Oncorhyncus nerka are anadromous salmonoid fishes that spend part of their life 
in the ocean.  After having spent 1 – 3 years feeding and growing in the Pacific Ocean, O. 
nerka will return to the site from which they were conceived.  Therefore, they must 
12 
 
 
power their way back to their birthplace to spawn, even though they ate their last meal at 
sea and will starve throughout their journey (Hill, p.3).  For a spawning Pacific salmon, 
there is a huge cost to reproduction.  The fish will die once it reaches its spawning 
grounds and releases its eggs.  The fish, however, must stay alive during this journey.  
More importantly, the fish must not only stay alive, but must remain reproductively 
viable.  The question then is what happens with the immune system that enables these 
fish, under such intensely harsh conditions to survive and reproduce.  An understanding 
of this process requires knowledge about the stress response in these animals and how 
that stress affects both the endocrine and immune systems.  At this point, it is important 
to also note that different taxa of fish have different stress tolerances, making this a very 
difficult field of study (Schreck et al, 2001).   
 Schreck et al. define stress as the “physiological cascade of events that occurs 
when the organism is attempting to resist death or reestablish homeostatic norms in the 
face of an insult” (Schreck et al, 2001).  While stress is generally believed to cause 
reduced immune capacity, a recent study in mice demonstrated that when these animals 
were subjected to multiple bite wounds they became resistant to the immunosuppressive 
effects of stress and glucocorticoids (Avitsur et al., 2000).  Avitsur et al. propose that this 
response is adaptive because it is optimal to maintain immune defenses in the face of 
numerous wounds.  Because fish encounter a number of obstacles (numerous wounds) on 
their way to their spawning grounds, an adaptive response similar to the one described by 
Avitsur et al. seems likely during spawning in fish.  It is apparent that stress and the 
immune system are closely related.  A more thorough understanding of this relationship 
requires an understanding of how key hormones modulate immunity in fish.   
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 For the purpose of this study, it was important to have a full understanding of the 
effects of cortisol on B-cells.  Cortisol is the primary corticosteroid produced during a 
stress response in the teleost interrenal gland; the interrenal gland of fishes is 
intermingled with other tissues.  More specifically, both steroidogenic (corticosteroid-
producing) and chromaffin (chatecholamine-producing) cells are scattered along the 
posterior cardinal vein and the hematopeoitic head kidney (anterior kidney) (Evans and 
Claiborne p. 288, Harris and Bird, 2000).  Administration of cortisol to teleost fish has 
been shown to reduce the number of circulating B and T lymphocytes.  It has been 
hypothesized that during a stress response, these cells are trafficked to lymphoid tissues 
such as the anterior kidney.  Additionally, cortisol has been shown to induce the 
apoptosis of B cells in carp lymphocytes (Weyts et al., 1997).  Wojtaszek et al. observed 
lymphopenia in the blood: after 24 hours there was a reduction from 63% to 20% in 
percent lymphocytes when cortisol was injected into the blood of carp (Wojtaszek et al., 
2002).  Maule and Schreck, studying O. kisutch, also noticed a decrease in the frequency 
of leukocytes in spleen and PBL, as well as increase in the anterior kidney, in response to 
acute stress or cortisol in food (Maule and Schreck, 1990).  Both lymphopenia and 
apoptosis of B cells could account for their clearance from the blood following stress.  
Cortisol has also been shown to reduce levels of phagocytosis and lymphocyte 
proliferation, as well as the activity of immunoglobulin producing cells and circulating 
levels of IgM (Harris and Bird, 2000).   
 In goldfish, there do not appear to be any immunosuppressive symptoms during 
spawning (Suzuki et al., 1996).  Yet, during spawning season, rainbow trout have 
decreased numbers of antibody secreting cells and lower IgM serum titers (Hou et al., 
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1999).   A study by Weyts et al. determined that increased cortisol correlates with 
increases in apoptosis of LPS-activated, but not resting, B lymphocytes in PBL (Weyts et 
al., 1998).   
 In carp, the number of IgM secreting cells in PBL, spleen, and anterior kidney are 
surprisingly high when cortisol levels are high (Saha, 2002).  These data are surprising 
because cortisol can induce apoptosis in the absence of a stimulant in carp (Saha, 2003).  
After incubation with 100ng/ml cortisol for 12 hours, ELISPOTS show the number of 
IgM secreting cells decreases in all three tissues (Saha, 2004).  ELISA analysis of IgM 
titer shows two days after cortisol incubation, there is a 15 – 20% decrease in all three 
tissues.  The reduction in antibody secreting cells may reflect an inhibiting effect of 
cortisol on proliferating B-cells (plasmablasts), but it is possible that the plasma cells are 
not affected by cortisol (Saha, 2004).  Glucocorticosteroids are thought to induce 
apoptosis by crosslinking IgM (Saha, 2003), which would explain why plasma cells, 
which do no longer express IgM on the cell surface, are less sensitive to cortisol.      
 A human study exploring the effects of cortisol on B-cells shows that cortisol has 
an inhibiting effect on B lymphopoiesis and inhibits the formation of pro- and pre-B 
cells.  Immature B-cells, in the presence of cortisol are apoptotic, and resting B-cells are 
less affected by cortisol.  The study, however, did not describe the effects of very high 
levels of cortisol on resting B-cells (Igrashi et al., 2005).   
 Rahman et al. studied the relationship between prednisolon, a glucocorticoid, and 
Pax5 in human B-cell lines.  While glucocorticoids are shown to induce apoptosis and 
arrest growth of pre-B cell lines (in agreement with the data presented above), prednisone 
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was shown to have no apoptotic effect on mature B, or pro-B cell lines.  Additionally, 
Pax5 protein and transcript levels are decreased after growth of pre-B cell lines in 
glucocorticoid medium, but no glucocorticoid response element was found on the Pax5 
promoter (Rahman et al., 2001).  This may point to cortisol effecting B-cells through the 
glucocorticoid receptor that is present on B-cells.  
 Based on the preceding studies, it is apparent that cortisol, and other 
glucocorticoids, have a profound impact on B-cells.  All developing B-cells are lost 
through inhibition of B lymphopoiesis, while pre-B cells, activated B-cells and possibly 
plasmablasts are lost through apoptosis.  Plasma cells and mature B-cells do not appear to 
be as profoundly affected by cortisol and may remain, even after an organism experiences 
acute stress.  Additionally, based on the study by Rahman et al. it is clear that Pax5 is 
affected by glucocorticoids.    
 Growth hormone and prolactin are two additional hormones produced during a 
stress response that have been shown to modulate the immune system in fish.  In fish, 
growth hormone is responsible for osmoregulation as well as steroidogenesis while 
prolactin is functionally important for growth, osmoregulation, and reproduction.  
Growth hormone has been shown to stimulate lymphopoiesis, phagocytosis, and 
immunoglobulin production in fish.  Additionally, prolactin has been shown to increase 
IgM levels in fish (Harris and Bird, 2000).   
 Reproductive hormones are also known to influence the immune system in fish 
(Harris and Bird, 2000).  While androgens are primarily associated with male humans, in 
fish, testosterone and androstenedione are major products of the female ovaries.  In fish, 
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testosterone has immunosuppressive effects.  It reduces the number of immunoglobulin 
producing cells and has been shown to kill leukocytes in vitro (Slater and Schreck, 1997).  
Direct counts of viable leukocytes after incubation with and without testosterone 
demonstrate that testosterone leads to a significant loss of leukocytes.  To induce 
significant immunosuppression, at least five days of contact with testosterone were 
required.  Addition of media from proliferating lymphocytes not exposed to testosterone 
was not able to reverse the immunosuppressive effects of the testosterone.  Thus, 
testosterone may exert its immunosuppressive effects through direct action on salmonid 
leukocytes (Slater and Schreck, 1997).   
 During the spawning process, salmonoids display high levels of reproductive 
hormones, including testosterone.  Both male and female salmonoids display immune 
deficiencies during this stage of their life cycle.  A study of Pacific salmon during 
spawning found positive correlations between plasma reproductive steroid levels and 
lysozyme activity and the number of immunoglobulin producing cells (Harris and Bird, 
2000).  This suggests that both the innate and adaptive immune system (humoral 
immunity) is activated during spawning.  
 From this brief overview of just three different hormones, it is clear that stress has 
a dramatic effect on the immune system of fish.  The study of the effects of hormones on 
the fish immune system is very complicated and will take many years to fully elucidate.  
However, it is known that hormones produced during reproduction and stress affect the 
immune system and have important implications for fish health.   
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Quantitative Real-Time PCR 
 Polymerase chain reaction (PCR) was developed in 1983 by Kary Mullis and is 
now a widely used technique that amplifies specific sequences of DNA.  Advancements 
in PCR technology combined with fluorescent technology led to the development of 
quantitative or real-time PCR.  Quantification of cDNA in real-time PCR is based on the 
measurement of the increasing fluorescence intensity after each PCR cycle (Ramackers, 
2002).  Measuring the kinetics of the reaction starting at the early phases of PCR provides 
a distinct advantage over traditional PCR detection which uses agarose gels for the 
detection of the PCR product at the end-point of the reaction.  The problems with end-
point detection include: not quantitative, poor precision, low sensitivity, low resolution, 
size based discrimination only, and results that are not expressed as numbers.  To further 
understand the limitations of end-point PCR, it is important to understand the key phases 
of a PCR reaction.  The reaction has three phases.  There is the exponential phase where, 
assuming 100% efficiency, there is exact doubling of the product.  There is the linear 
phase where the reaction components are consumed and the reaction is slowing.  Lastly, 
there is the plateau, where the reaction has stopped and if left long enough the product 
will degrade.   The plateau is what is measured with traditional end-point PCR methods 
(Figure 5).  Measurements taken at the plateau phase do not truly represent the starting 
amounts of target material (ABI).   
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Figure 5:  Logarithmic view of PCR phases (ABI). 
 Real-time PCR measures the amount of amplicon during the exponential phase of 
the PCR reaction making the quantitation of DNA both easier and more precise than with 
traditional methods. This Honors research used SYBR Green Dye to perform real-time 
analysis.  SYBR Green dye binds to the minor groove of double stranded DNA (Figure 
6).  As more amplicons are produced, the intensity of the fluorescence increases.  The 
main drawback to SYBR Green Dye is that it is not as precise as other available probes 
because instead of binding to a specific sequence of DNA, SYBR green will bind to any 
DNA that is double stranded.  This can cause issues if the primer sticks to itself forming a 
primer dimer (ABI).    
 
Figure 6: SYBR Green binding (NFSTC). 
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 Thus, while setting up a real-time assay can be a challenge, there are a number of 
advantages to using Real-Time PCR over traditional PCR.  First, Real-Time PCR collects 
data in the exponential growth phase while traditional PCR measures a plateau.  Second, 
an increase in fluorescent signal is directly proportional to the number of amplicons 
produced by the reaction.  Third, cleavage of the probe provides a permanent record of 
amplification of the amplicon; thus, degredation of the final product does not lead to 
inaccurate data.  Finally, Real-Time PCR is capable of detection down to a 2-fold change 
making it much more precise than the traditional end-point method with agarose gel 
(ABI).   
Research Question, Hypothesis, and Relevance 
Research Questions 
1. Are there changes in the alternative splicing of Pax5 during a humoral immune 
response in the genus Oncorhynchus? 
2. Specifically, what changes are seen in Oncorhynchus Pax5 isoforms that lack 
exon 2 and does this correlate with an increase in the levels of secreted IgM? 
Hypothesis 
 There are changes in alternative splicing of Pax5 during a humoral immune 
response in the genus Oncorhynchus.  Specifically, as the levels of Pax5Δ2 increase, the 
levels of secreted IgM also increase.   Pax5Δ2 is acting as co-repressor of Pax5FL. 
 This project aimed to use quantitative real-time PCR to determine whether there is 
a relationship between the alternative splicing of Pax5 and a humoral immune response in 
Oncorhynchus.  The project used both an in-vivo and an in-vitro model to explore this 
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relationship.  For the in-vitro model, we stimulated rainbow trout B cells with LPS.  As 
the cells become stimulated, we predicted that the level of secreted IgM would increase 
and, based on this hypothesis, the levels of Pax5Δ2 would also increase.  This prediction 
was based on the work by Zwollo et al. stating that Pax5Δ2 may act as a co-repressor of 
Pax5FL (Zwollo et al. 1997).  Additionally, for the in-vivo model, immune tissues from 
O. nerka were collected from different locations on the path of fish to the spawning 
grounds.  We hypothesized that the fish would maintain some level of humoral immune 
response as they get closer to their spawning ground in order to maintain their health so 
as to not lose their reproductive abilities.  An increase in the levels of secreted IgM was 
predicted to cause an increase in the level of Pax5Δ2 expression.   
 Our hypothesis that Pax5Δ2 is acting as a co-repressor of Pax5FL is, in part, 
based on a study by Lowen et al.  that illustrates that Pax5FL modulated by alternatively 
spliced isoforms.  Through comparison of various B-cell lines and resting and LPS 
activated mature B-cells, Lowen et al. concluded that increased B-cell proliferation 
correlates with increased levels of Pax-5e, an isoform missing both exon 2 and exons 6-
10 (transactivation domain).  Conversely, they also demonstrated that increased Pax-5d, 
an isoform missing exons 6-10, correlated with inhibition of cell growth.  These findings 
together led the researchers to conclude that during activation and differentiation of B-
lymphocytes, Pax5FL is modulated by alternatively spliced isoforms (Lowen et al., 
2001).  The current honors research aimed to determine how Pax5Δ2 fits into this picture. 
 Determining the expression patterns and ultimately the function of the Pax5Δ2 
isoform is interesting because this isoform is missing a portion of the paired domain.  
Because of the missing exon in the paired domain region, the isoform may have altered 
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co-transactivating or co-repressive capabilities, which implies that the isoform has 
interesting and important functions in B-cells.  Studies performed on the Pax8 and Pax6 
genes indicate that isoforms with altered paired domains lose sequence specificity and are 
subsequently able to bind to other areas with greater affinity than their traditional binding 
site.  However, the presence of a homeodomain (Pax 6) can help to stabilize the weak 
DNA interactions of the Paired Domain while proteins lacking a homeodomain (Pax 8) 
may be able to interact with other proteins if the Paired Domain has been altered 
(Kozmik et al, 1997).   
 This research could have a number of clinical applications specifically in the area 
of lymphomas.  The human Pax5 gene has been implicated as a tumor suppressor or as an 
oncogene in leukemias as well as non-Hodgkin lymphomas and other lymphoid 
malignancies (Decker et al, 2008).  Discovery of a Pax5 enhancer in the intron of exon 5 
provides insight into the role of Pax5 cis-regulatory elements in chromosomal 
translocations that are implicated in the development of B-cell precursor acute 
lymphoblastic leukemia (BCP-ALL).  In BCP-ALL, translocations of Pax5 generate 
novel transcription factors through the fusing of the N-terminal DNA-binding domain of 
Pax5 to the C-terminal sequences of other transcription factors, kinases, and structural 
proteins (Decker et al, 2009).  Additionally, research conducted in CLL patients 
established that the predominant expression of full length Pax5 is generally accompanied 
by minor expression of various isoforms and that most of these isoforms are indeed 
translated into proteins.  Therefore, we have a clear link between Pax5 isoforms and 
lymphomas indicating that this research could prove to be very important from the 
clinical perspective.  
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 Recent advances in mammalian Pax5 studies suggest that Pax5 is able to activate 
the transcription of human telomerase reverse transcriptase gene in B cells.  This is 
important because it suggests that in addition to regulating the development and 
activation of B-cells, Pax5 can affect the immortality of a cell (Bougel et al, 2009).  It 
would be very interesting to determine if the various isoforms of Pax5 play any role in 
regulating cell immortality.  This would be important news in the cancer research world. 
 Lastly, this study furthers our understanding of how salmonoid species are able to 
travel thousands of miles from salty water to fresh, enduring attack by thousands of 
parasites and diseases, and still have viable gametes with which to reproduce at their final 
destination.  A deeper understanding of this process could then be applied in a 
comparative physiology context.
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Methods 
Animals and facilities 
 Outbred rainbow trout (200-500 grams) were gifts from Dr. Steve Kaattari 
(Virginia Institute of Marine Science). Fish were maintained in a 100-gallon tank with a 
re-circulating system employing filtered well water. Fresh water exchange was 
approximately 10% per day. Water temperature was maintained at 12°C. Fish were fed 
dry, floating pellets (Aqua Max Grower 600, Purina) once a day. 
Tissue Collection and Storage 
 Immune tissues from wild sockeye salmon (Oncorhyncus nerka) were collected 
by Dr. Zwollo from four sites in South Central Alaska, in accordance with an approved 
IACUC protocol.  These included the Main Bay (Prince William Sound), Mouth of the 
Kenai River, Russian River, and Quartz Creek-Upper Kenai River (Figure 7).  Live fish 
were donated by local fishermen, and dissected immediately by Dr. Zwoll.  
Approximately 0.3-0.5 cubic cm samples from spleen, anterior kidney and posterior 
kidney were collected into 750-1000ul  ul of RNAlater reagent (Applied Biosystems Inc.) 
and stored overnight at 4C, then frozen at -20C until use.  100 µl blood samples were 
collected into 750 µl RNA later (Ambion). 
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Figure 7: Locations of fish collection. 
 Rainbow trout were anesthetized with ethyl-3-aminobenzoate methanesulfate salt 
(Sigma) in accordance with our IACUC protocol.  Blood was collected in heparinized 
tubes and spleen tissues in 5 mls sterile HBSS (137 mM NaCl, 5.6 mM D-glucose, 5 mM 
KCl, 8.1 mM Na2HP04.2H20, and 20 mM Hepes at pH 7.05).  Single cell spleen 
suspensions were obtained by repeated uptake and release through a 10 ml syringe 
followed by forcing cells through a 40 nm nylon cell strainer (Falcon/BD Biosciences). 
Erythrocytes were removed using Histopaque 1077 cushions (Sigma Aldrich) and spun at 
500g at 4 °C for 30–45 min and cells collected in HBSS or PBS (1.9 mM NaH2P04.H20, 
8.1 mM Na2HP04.7H20, 137 mM NaCl, and 2.6 mM KCl, pH 7.4) containing 0.02% 
sodium azide (PBS-SA). 
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LPS Activation 
 Freshly isolated splenic trout cells with erythrocytes removed were cultured in 
trout culture medium (TCM) consisting of RPMI 1640 with 10 mM L-glutamine, 10% 
Fetal Calf Serum, 50 µg/ml gentamicin, 50 µM 2-ME, and the nucleosides adenosine, 
uracil, cytosine, and guanosine (10 µg/ml; Sigma-Aldrich) at 18C and in the presence of 
blood gas (10% CO2, 10% O2, 80% N2).  Cells were activated using lipopolysaccharide 
(LPS) (055:B5 from E.coli; Sigma) at 100 µg/ml.  Cells were fed every other day with 
one tenth of the culture volume of a 10x tissue culture cocktail containing 500 µg/ml 
gentamycin, 10x essential amino acids (aas), 10x non-essential aas, 70 mM L-glutamine, 
70 mg/ml dextrose, 10x nucleosides, and 33% FBS.  Cells were collected on the indicated 
days and frozen at -80C until RNA purification. 
RNA Extraction 
 RNA was extracted using the TRIzol Reagent (Invitrogen).  50 mg of tissue was 
homogenized into 2ml of TRIzol using a Fisher PowerGen 125.  Next, due to the high 
content of proteins in the samples, following homogenization samples were spun at 
12000g for 10 min to remove insoluble material.  The cleared homogenate solution was 
transferred to a fresh tube and 0.4 ml of chloroform was added to remove soluble protein.  
Samples were vigorously shaken for 15 seconds.  Following a 3 min incubation at room 
temperature and a 10 min spin at 12000g, the solution was separated into a red phenol-
cholorophorm phase, an interphase containing protein, and a colorless upper aqueous 
phase containing the RNA.  The aqueous phase was transferred to a fresh tube and one-
half a volume (1ml) isopropyl alcohol added to precipitate the RNA.  Samples were 
incubated at room temperature for 10 min and then spun at 12000g for 10 min.  The RNA 
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precipitates as a gel-like pellet on the side and bottom of the tube.  Subsequently, the 
RNA was washed using 2 mls 75% ethanol, to remove excess salts, the tube vortexed, 
and spun at 7500g for 5 min.  The RNA pellet was then air-dried for 10 min and 
resuspended in 40µl RNase-free water.  RNA concentration was determined using the 
NanoDrop™ ND-1000 full-spectrum (220nm-750nm) spectrophotometer.  RNA quality 
was checked by gel electrophoresis. 
cDNA and Real-Time PCR 
 1µg of total RNA was used in a 20µL volume to make cDNA using the iScript kit 
(BioRad).  Quantitative real-time PCR was performed using a PerfeCta SYBR Green 
SuperMix, ROX PCR kit (Quanta Biosciences) with a reaction mix containing 12.5µL 
SYBR Green, 9.5µL RNase free water, 1µl each primer (Table 1 and Figure 8), and 1µL 
cDNA in 25µL of total reaction volume on an Applied Biosystems StepOne Real-Time 
PCR instrument.  As a means of quality control for each run, negative controls were 
included in each plate set-up where cDNA template was substituted by equal amount of 
nuclease free water.  Each RNA template, before being transcribed to cDNA was used in 
equal concentration in PCR reaction as a means to ensure no PCR amplification of 
possible leftover genomic DNA in the sample.  Initial run analysis was performed using 
StepOne Software Version 2.1.   
 Before beginning the real-time PCR experiments, a validation experiment was 
performed to verify that the efficiency of the reference (tubulin) primer and target 
primers were approximately equal.  To assess the efficiency of the primers, serial 
dilutions of target and tubulin primers were prepared and real-time PCR was performed.  
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The CT values for each dilution for target and tubulin were obtained and the ΔCT value 
was calculated.  Next, a plot of the log input amount versus the ΔCT value was prepared.  
A slope of approximately zero indicates that the efficiencies of the two amplicons are 
approximately equal (Dorak). 
 To confirm that only one product of the correct size was being amplified by the 
primers, the products from a real-time PCR reaction were run on a 2% agarose gel.  The 
first well contained a 1kb ladder and the remaining wells contained 5µL of 6X dye and 
25µL of PCR product.  The gel was run at 70mV for 1 hour. 
 Additionally, to confirm that the Onchorynchus spp. Pax5 was being amplified by 
the primers, the real-time PCR fragment was sequenced.  Direct sequencing was 
performed by capillary electrophoresis on ABI 3130 Avant Genetic Analyzer.  
Sequencing PCR reactions were carried out with BigDye Version 3.1 chemistry in both 
direction.  BioEdge columns were used in PCR clean-up before denaturing purified 
samples in HiDi formamide.  Samples were resolved on a 36cm capillary and Pop7 
polymer.  Sequences were analyzed on ABI sequencing software version 5.1.  An NCBI 
Blast tool was used to align obtained sequences with the published Onchorynchus spp. 
sequence data.     
 PCR was run under the following conditions for the secreted (qt.HCmu.sec.AS 
and qtHCmu.S) and membrane IgM (qtHCmu.mem.AS and qtHCmu.S): cDNA was 
denatured at 95.0 ⁰C for 10 min.  After this, sample was exposed to 95.0 ⁰C for 15sec and 
60 ⁰C for 1 min for 40 cycles in a two-step PCR reaction.  Finally, a one-time increase to 
95 ⁰C for 15 sec generated the melt curve.  The reaction was run under the following 
28 
 
 
conditions for the Pax5FL and Pax5Δ2 primers: cDNA was denatured at 95.0 ⁰C for 10 
min.  After this, sample was exposed to 95.0 ⁰C for 15 sec and 56 ⁰C for 1 min for 40 
cycles in a two-step PCR reaction.  Finally, a one-time increase to 95 ⁰C for 15 sec 
generated the melt curve which served as a quality control measurement.  Each sample 
was measured in triplicate. Tubulin, PaxFL, and PaxΔ2 were run together in one assay 
while tubulin, secreted, and membrane IgM were run together in another assay. With the 
48-well machine, five samples were run with three primer sets in each reaction. 
Table 1: Primer Information 
Primer Name Primer Target Primer Sequence 
qtHCmu.S Secreted and Membrane 
IgM 
5’-GCG CTG TAG ATC ACA TGG 
AA-3’ 
qt.HCmu.sec.AS Secreted IgM 5’-GCA AGT CAG GGT CAC CGT 
AT-3’ 
qtHCmu.mem.AS Membrane IgM 5’-TTT CAC CTT GAT GGC AGT 
TG-3 
Ttub60.F Tubulin 5’-CGT CCC CAG GTG TCC ACT-3’ 
Ttub60.R Tubulin 5’-GTA GGT GGG GCG CTC AAT-3’ 
tPax5/E3-4.AS Pax5FL and Pax5Δ2 5’-CCT GAT GAT CCT GTT GAT 
AGA-3’ 
tPax5E2.S Pax5FL 5’-CAC GGA TGT GTC AGC AAG 
AT-3’ 
tPax5/E1-3.S Pax5Δ2 5’-CGG GAC GAG CAG GTA CTA 
TG-3’ 
Ttub56.F Tubulin 5’-TTC ACC TCC CTG CTG ATG-3’ 
Ttub56.R Tubulin 5’-CCA CCA TGA AGG CAC AGT-3’ 
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Figure 8: Primer Location.  This figure illustrates where each primer binds.  The Pax5FL 
product produced by primers tPax5E2.S and tPax5/E3-4.AS is 237 base pairs in length 
while the Pax5de2 product produced by primers tPax5/E1-3.S and tPax5/E3-4.AS is 198 
base pairs in length. 
Analysis of Quantitative Real-Time PCR 
 After the reaction was complete, CT values provided by the real-time PCR 
instrument were exported as a .txt file onto a USB drive.  The data were then uploaded 
into DataAssist Software (ABI).  The Pax and Sec/Mem assays had to be analyzed 
separately. Multiple experiments were combined in one DataAssist study to enable 
analysis of all 2009, 2010, and OM samples to be studied together, respectively.  
Expression levels were calculated as fold-change relative to the Day0 fish for LPS 
activated cells and to the reference sample (averaged O. mykiss CT) for the O. nerka 
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samples.  Expression of individual genes from each sample was normalized to relative 
expression of trout α-tubulin within the same experiment.  Results from DataAssist 
Software were exported to Excel for graphing and statistical analysis.   
 In DataAssist, for each study, PaxFL, PaxΔ2, Secreted, and Membrane were 
selected as ‘Targets’ and Tubulin as a ‘Selected Control’ in the ‘Assay Design’ section of 
the form.  In the ‘Analysis Settings’ box, the maximum allowable CT value was set at 
35.0, ‘Yes’ was selected in the ‘Include maxCT values in calculations’, the box for 
‘Exclude outliers among replicates’ was checked, ‘Arithmetic Mean’ was selected as the 
normalization method, and the Reference Sample was selected based on the assay being 
analyzed (averaged values of the OM Samples for all O. nerka data).  After pressing 
“Perform Analysis” the software generates the average CT, ΔCT, and fold change values 
for each sample.  Results from DataAssist Software were exported to Excel for graphing 
and statistical analysis.   
The following equation was used by DataAssist to calculate the ΔCT (1). 
    ΔCT = CT,Target – CT,Tubulin    (1) 
The ΔΔCT value was calculated separately in an Excel spreadsheet (2): 
             ΔΔCT = (CT,Target - CT,Tubulin)SampleX – (CT,Target – CT,Tubulin)Ref Sample (2) 
Finally, the fold change, or amount of target, was calculated by DataAssist according to 
the following equation (3) (Livak and Schmittgen, 2001).    
      Fold Change = 2-ΔΔCT  
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   (3) 
 The ratio of Fold Change Secreted/Fold Change Membrane as well as the ratio of 
Fold Change Pax5FL/Fold Change PaxΔ2 was calculated in an Excel spreadsheet.  These 
ratios were then input into a scatterplot to calculate the slope of the line and the 
correlation coefficient in order to determine if there was a correlation between the 
alternative splicing of Pax5 and an immune response in these samples (See Attachment 1 
for more information on the ΔΔCT method).   
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Results 
 The research presented in this thesis had the following two goals.  The first goal 
was to determine if there are changes in the alternative splicing of Pax5 during a humoral 
immune response in teleost fish.  Specifically, the aim was to determine what changes are 
seen in the levels of both the full length Pax5 form and any isoforms that lack exon 2 
(delta 2) and whether these changes correlate with an increase in the levels of secreted 
IgM.  The second goal aimed to determine if there are changes in Pax5 delta2 usage 
during the spawning period of Oncorhyncys nerka, and whether this correlates with the 
increased antibody response observed during spawning.  To do this, we initially measured 
IgM and Pax5 transcript levels in Oncorhynchus mykiss immune tissues during an in-
vitro LPS response, to provide a controlled system to study how Pax5 alternative splicing 
is altered during an immune response.   Two real-time PCR assays were designed and 
used to analyze samples.  Next, this technique was then used to analyze immune samples 
collected from four locations along the O. nerka spawning grounds in South Central 
Alaska.  The following section describes the data collected over the course of the study.   
Observation of Fish Location and Health 
 To obtain a full understanding of the relationship between alternative splicing and 
an immune response as a result of spawning, it was important to take detailed notes on 
both on the location and health of each fish. These notes also served as a point of 
comparison with the qPCR data.  As the fish were collected, they were assigned a 
number, which was used in the remainder of the project.  The location where the fish was 
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caught was also noted.  This location became very important as we assessed whether 
alternative splicing changes during the spawning process.  Finally, a brief description of 
each fish was documented.  This description included sex and overall health and any 
other characteristics seen in specific organs.  See Tables 2A and 2B provide a full 
description of each fish.   
Sample 
Name 
Location 
Caught 
Description of Fish 
51 Mouth Kenai 
River 
Female, large spleen, lots of worms around eggs 
52 Mouth Kenai 
River 
Female, regular size spleen, healthy, worms around eggs, 
bloody PK 
53 Mouth Kenai 
River 
Male, regular size spleen, looked healthy, large fish, grainy 
brown PK (aged?), no worms 
54 Russian/Kenai 
River 
Male, healthy, some worms, bloody PK, small spleen 
55 Russian/Kenai 
River 
Male, healthy, no worms, good PK and AK, spleen average 
size 
56 Russian/Kenai 
River 
Female, small spleen, large fish, grainy brown PK, AK, and 
SPL 
Table 2A – List of samples from 2009 fish collection. 
  Sample 
Name 
Location Caught Description of Fish 
101 Main Bay  Female, healthy, no spawning colors 
102 Main Bay  Female, bite marks, infection on abdomen, appeared 
healthy overall, no spawning colors 
103 Main Bay  Female, average size, healthy, no spawning colors 
104 Main Bay  Female, average size, healthy, no spawning colors 
105 Mouth of Kenai River  Male, large, healthy 
106 Mouth of Kenai River  Male, small, worms, mottled liver, grainy kidney, regular 
size spleen 
107 Mouth of Kenai River  Male, healthy, no worms, big spleen 
108 Russian River  Female, many worms, small eggs, whole body net marks, 
small spleen 
109 Russian River  Male, large, small spleen, no worms 
110 Quartz Creek‐Upper 
Kenai River 
Spawned Female, lots of worms, no eggs, stomach cavity 
jellied, hard small spleen with granules 
111 Quartz Creek‐Upper 
Kenai River 
Male ‐ spawned but still some milt loose in stomach 
cavity, only a few worms 
112 Quartz Creek‐Upper  Male ‐ bite mark in right shoulder area, few worms, 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Kenai River  spawned 
Table 2B – List of samples from the 2010 fish collection. 
RNA Quality Control 
 For real-time PCR applications, RNA quality is vitally important for obtaining 
accurate results.    The assay’s sensitivity may be reduced and the relative differences in 
transcripts may produce incorrect target ratios if RNA is partially degraded or has 
impurities (Bustin et al., 2009).  The RNA concentration and purity of all samples was 
tested by spectroscopy using the NanoDrop prior to cDNA synthesis and use in qPCR.  
Due to the tissue collection and the inherent nature of immune tissue, high quality RNA 
was difficult to achieve.  After testing various RNA extraction protocols, including 
Quiagen Kits and Trizol reagent, Trizol reagent was found to be most effective for 
obtaining high quality RNA for quantitative PCR.  DNAfree, a reagent containing 
DNase, was tested to try to improve RNA quality.  While the reagent was able to remove 
DNA contamination, it also significantly reduced the RNA yields.  If samples had very 
low 260/280 or 260/230 ratios, (the 260/280 should be higher than 1.9 and the 260/230 
ratio higher than 2.0 (Jain et al. 2006)) the samples were run on a 2% agarose gel to 
determine if RNA was of high enough quality for use in assay.  High quality RNA 
produces only two bands when run on a gel the bands are 18S and 28S ribosomal RNA.  
Low quality RNA produces a smear down the lane.  Table 3 provides an example of 
RNA concentration and purity in this experiment (See Attachment 1 for more details 
about RNA in this study). 
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Sample Name  [ng/µL] A260:A280 A260:A230 
SPL 101 207.87 1.89 2.11 
SPL 102 124.60 1.81 2.32 
SPL 103 97.59 1.89 1.92 
SPL 104* 24.08 1.89 1.36 
SPL 105 112.55 1.92 1.72 
SPL 106 174.70 1.90 2.00 
SPL 107 1911.25 1.99 1.64 
SPL 108 2977.05 1.96 1.73 
SPL 109 1927.51 1.97 1.74 
SPL 110 1638.18 2.02 1.98 
SPL 111 2262.60 1.96 1.45 
SPL 112 1690.77 1.96 1.54 
Table 3: RNA Quality Control NanoDrop Data.  * Samples with very low concentration 
used 0.5µg RNA to make cDNA and then 2µL cDNA in each reaction to make amount of 
target the same for each reaction. 
Real-Time PCR Assay Validation 
 A large part of completing a qPCR experiment involves designing the assay.   
Primers must be carefully designed to prevent non-specific binding as well as primer 
dimers.  Additionally, the primers must be tested at a number of different concentrations 
and melting temperatures.  The products of the reaction must be relatively small (under 
200 base pairs) because of the two-step nature of the reaction, and lack of a 72 ⁰C 
extension step which would be required to produce a longer product.  Quality of the 
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reaction can be assessed by a number of plots produced by the machine.  The 
amplification plot (Figure 9) shows the amount of background fluorescence being 
produced as well as the logarithmic curve produced as product is formed.  The melt curve 
(Figure 10) is the main indicator of primer efficiency.  If the curve has multiple peaks it 
indicates that there is unspecific binding occurring.  If the curve has one peak around 70 
degrees and another in the 80 degree range, this shows that a primer dimer is forming.  
Additionally, if the melt curve has more than one peak, it indicates that multiple products 
are being formed.  It is important to note the temperature difference between the primer 
dimer and the desired product.  The primers that this project used for Pax5FL 
amplification form a primer dimer.  This means that the negative control is not negative, 
but because the primer dimer melts at approximately 70 degrees and the melt curve for 
samples was melting around 85 ⁰C, this is not a critical problem.  The multicomponent 
plot (Figure 11) shows the level of fluorescence as compared to the baseline and verifies 
that the machine is functioning properly.   
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Figure 9: Sample Amplification Plot.  The short, jagged lines indicate background 
fluorescence in the reaction while the logarithmic lines show the amplification of product 
during the reaction.   
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Figure 10: Sample Melt Curve.  The three different curves are produced by the three 
different primer sets in the reaction (Tubulin, Secreted IgM, and Membrane IgM).  The 
single peak indicates that only one product is being formed during the reaction.  The 
yellow-green curve is the melt curve for the Tubulin primers, the purple and pink curve is 
the melt curve for the membrane primers, and the teal curve is the melt curve for the 
secreted primers. 
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Figure 11: Sample Multicomponent Plot.  The SYBR lines below the ROX baseline are 
produced by the negative control samples. 
 As an additional step to verify that the primers are all amplifying at approximately 
the same efficiency, a validation experiment was run at each melting temperature.  In 
these experiments, all primer sets were run at 56 ⁰C and 60 ⁰C with varying 
concentrations of primer.  The experiment verified that 1 µL of primer in each reaction 
was optimal because, even though most of the primers worked very efficiently at a much 
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lower concentration, the Pax5FL primer set worked most efficiently with 1 µL of primer 
and primer concentration needs to be standardized in the assay. 
 
Figure 12A: Validation assay for Tm = 56 ⁰C.  Primers were all working at 
approximately the same efficiency and that the assay was amplifying product optimally at 
56 ⁰C with 1 µL primer for the Pax primers and at 60 ⁰C with 1 µL primer for the IgM 
primers.  
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Figure 12B: Validation assay for 60 ⁰C.   
Sequencing and Gel Electrophoresis to Verify Primer Specificity 
 To verify that the primers were amplifying the desired Pax5 products, qPCR 
product was sequenced and the resulting sequence was compared to published sequences 
in the NCBI website using the BLAST tool.  Sequences were as expected based on 
published data (refer to NCBI Reference Sequence: NM_001124682.1). 
 Additionally, the products from both an IgM and a Pax real-time PCR run were 
analyzed using gel electrophoresis.  Figure 13 verifies that each primer set is producing 
only one product of approximately the expected size.  The Tubulin 56 product is 165 base 
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pairs, the PaxFL product is 237 base pairs, and the Pax5Δ2 product is 198 base pairs.  
The Tubulin 60 product is 154 base pairs, the secreted product is 143 base pairs, and the 
membrane product is 177 base pairs. 
 
Figure 13: Gel of qPCR products, showing that only one product is formed in each 
reaction. 
LPS Activation to Determine if B-cell Activation Correlates with Usage of Pax5Δ2  
 SPL and PBL cells were freshly isolated from O. mykiss samples and cultured in-
vitro in the presence of LPS.  Cells were collected on days 0, 2, 4, and 7.  Real-time PCR 
was performed on the samples using the primers discussed above.  Figures 14 and 15 
show scatter plots of the ratio of secreted/membrane IgM and the ratio of Pax5Δ2/Pax5FL 
for SPL and PBL respectively.  These plots show a positive correlation between the 
levels of secreted IgM and Pax5Δ2.  For this project, four sets of LPS activation were 
analyzed.  The results from each set are quite different, but the following scatter plots 
illustrate the general pattern that was expected based on previous research.  A large die-
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off of cells between Day 0 and Day 2 occurred, thus the data points illustrated are for Day 
2, Day 4, and Day 7.  More LPS studies need to be completed to verify these results. 
 
Figure 14:  Scatter plot of the ratio of secreted/membrane IgM and the ratio of 
Pax5Δ2/Pax5FL for SPL LPS activation.   
 
Figure 15: Scatter plot of the ratio of secreted/membrane IgM and the ratio of 
Pax5Δ2/Pax5FL for PBL LPS activation. 
Levels of IgM and Pax5 During Spawning 
 To analyze how the levels of IgM and Pax5 change during spawning in O. nerka, 
we needed to find a suitable negative control for the spawning fish.  Because it is very 
difficult to obtain fish from the open ocean, where levels of IgM and Pax5 would not yet 
have been subjected to the effects of spawning, an alternative negative control was 
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necessary.  For this experiment, O. mykiss fish from the laboratory were used as a 
negative control.   
 Real-time PCR was run using the O. mykiss anterior kidney, posterior kidney,  
spleen and PBL samples and the IgM and Pax5 primers, as described above.  These 
samples, which should not be exhibiting an immune response, show a positive correlation 
between secreted IgM and Pax5Δ2 levels, consistent with the results of the LPS 
experiment for SPL and PBL.  The correlation is not seen in the anterior kidney due to 
the large number of B cells at different developmental and activation stages within this 
organ: anterior kidney is the site of both B-cell lymphopoeisis and storage of long-lived 
plasma cells.  The presence of a large number of plasma cells, which are secreting large 
quantities of IgM, but have no Pax5, could have a strong influence on the data for this 
tissue.  Additionally, at the current time, not enough is known about the maturational 
stages of B-cells in the posterior kidney to make analysis of these data beneficial.     
  
 
Figure 16: O. mykiss SPL shows a strong positive correlation between Secreted IgM and 
Pax5Δ2.   
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Figure 17: O. mykiss PBL shows a positive correlation between Secreted IgM and 
Pax5Δ2.  
 Data from real-time PCR of all samples using the primers and methods described 
above was graphed in many different ways in order to determine the correlation between 
secreted IgM levels and Pax5Δ2 for the spawning O. nerka samples.  The following 
figures show the ratio of Secreted/Membrane IgM for each individual fish, the ratio of 
Pax5Δ2/Pax5FL for each individual fish, and then the correlation between these two 
ratios.  Due to small number of samples, random variation between samples has a large 
effect on the patterns generated by the data.  The data are shown in the form of ratios in 
order to reduce the effects of these random variations between different samples of the 
population.   
 A difference in the ratio of secreted/membrane IgM and subsequently the ratio of 
Pax5Δ2/Pax5FL was expected between male and female fish based on the literature.  
After graphing the sexes separately, a pattern was not apparent (see Appendix). Sex is 
indicated in the following graphs. 
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 The SPL and PBL of spawning O. nerka samples exhibit the same positive 
correlation between secreted IgM and Pax5Δ2 that was seen in our highly defined O. 
mykiss immune response generated through LPS activation (Figure 20 and Figure 23 
respectively).  A scatter plot showing the correlation between the secreted IgM and 
Pax5Δ2 is shown for AK and PK (Figure 26 and Figure 29).  We see no correlation 
between IgM and Pax5  levels in these tissues due to the complex nature of the B-cell 
types found in the tissues (as described above).    
 
Figure 18: SPL Ratio of Sec/Mem IgM.  Sample location and sex indicated on graph.  
All O. nerka samples (numbered) had much higher levels of secreted IgM than O. mykiss 
(OM) negative controls.  Ref refers to the sample used as a reference for the OM samples.  
OM samples were then used as the reference for the O. nerka analysis.   
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Figure 19: SPL Ratio of PaxΔ2/PaxFL.  O. nerka samples 54, 55, 56, and 111 have very 
low levels of PaxFL.  Samples from the Main Bay had levels of Pax5 similar to those 
seen in the O. mykiss (OM) samples.   
 
Figure 20: Scatter plot comparing the ratio of Pax5Δ2/Pax5FL with the ratio of Sec/Mem 
IgM.  R2 value of 0.4267 indicates a positive correlation between secreted IgM and 
Pax5Δ2.  
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Figure 21: PBL Ratio of Sec/Mem IgM.  All samples had very low levels of secreted 
IgM except for the two spawned males.   
 
Figure 22: PBL Ratio of PaxΔ2/PaxFL.  O. mykiss (OM) samples had higher levels of 
Pax5 than O. nerka samples except for the two spawned males. 
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Figure 23: Scatter plot showing the correlation between the ratio of Pax5Δ2/Pax5FL and 
Sec/Mem IgM.  R2 value of 0.7414 indicates a positive correlation between secreted IgM 
and Pax5Δ2. 
 
Figure 24: AK Ratio of Sec/Mem IgM.  Secreted IgM levels were higher in the O. nerka 
than in the O. mykiss (OM).    
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Figure 25: AK Ratio of Pax5Δ2/Pax5FL.   
 
Figure 26: Scatter plot showing the correlation between the ratio of Pax5Δ2/FL and the 
ratio of Sec/Mem IgM.  R2 value of 0.1838 indicates no correlation between the data.   
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Figure 27: PK Ratio of Sec/Mem IgM.  Spawning samples generally had higher levels of 
secreted IgM than the O. mykiss (OM) samples.  Spawned fish reversed to lower levels of 
secreted IgM. 
 
Figure 28: PK Ratio of PaxΔ2/PaxFL.   
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Figure 29: Scatter plot showing the correlation between the ratio of Pax5Δ2/Pax5FL and 
the ratio of Sec/Mem IgM in the PK.  R2 value of 0.1277 indicates no correlation between 
the data.   
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Discussion 
 The main goal of this project was to determine if there is a correlation between 
the alternative splicing of Pax5 and an immune response in Onchorynchus spp.  Here we 
showed that the level of Pax5Δ2 positively correlates with the levels of secreted IgM in-
vitro in LPS activated O. mykiss B-cell, in-vivo in O. mykiss samples, and in-vivo in O. 
nerka samples.  Pax5 has previously been shown to be alternatively spliced in mouse B-
cells (Zwollo et al., 1997).  Alternatively spliced isoforms are thought to function through 
a number of different mechanisms including: changes in DNA binding properties, 
differential interaction with co-activators or co-repressors, or through changes in 
interaction with the transcription initiation complex (Zwollo, 2011).  Previous research in 
the Zwollo lab has shown that mouse B cells, in addition to expressing the full-length 
form of Pax5, Pax5FL, express at least three different isoforms.  One of these isoforms, 
isoform Pax-5b (Pax5Δ2) has a deletion of exon 2, resulting in a Pax5 protein with a very 
short paired domain that is unable to bind DNA in vitro (Zwollo et al., 1997).  Our lab 
subsequently showed that O.mykiss also expresses this isoform in B cells.   
IgM Changes During Spawning (Humoral Immune Response during Spawning) 
 From the data presented here, it appears that during spawning, there is a relative 
increase in the levels of secreted IgM compared to the levels of membrane IgM.  
However, the absolute levels of secreted IgM were decreased in spawning fish.  These 
results make sense when one considers what happens to the fish as it moves towards the 
spawning grounds.  First, the fish will need some sort of immune activity to fight 
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pathogens encountered during the trip.  Cortisol levels, which are highly increased due to 
the spawning-induced stress response, will have a profound immunosuppressive effect on 
the fish.  All developing B cells are lost through the inhibition of B-lymphopoiesis. In 
addition, pre-B cells, activated B-cells and possibly plasmablasts are lost through 
apoptosis, but plasma cells and mature B-cells do not appear to be strongly affected by 
cortisol (Harris and Bird, 2000).  Thus, there is a decrease in absolute levels of both 
membrane and secreted IgM due to the effects of cortisol, but a relative increase in 
secreted IgM, because cortisol does not appear to be affecting the plasma cells directly.   
 Before beginning this project, it was hypothesized that male and female samples 
would have different patterns of expression for relative IgM levels and, in turn, relative 
Pax5 levels.  The rationale for this hypothesis was that the female immune system would 
have to be more strongly activated in order to provide and pass on Ig-protection to the 
eggs (Swain and Nayak, 2009).  Maternal immunity transmission is defined as the 
transfer of immune factors from an immunocompetent female to an immunologically 
naïve neonate through yolk.  Successful transfer of maternal IgM to eggs and embryos 
has been documented in several teleostean fishes including the rainbow trout.  In fish, 
both innate and adaptive immunity are transferred from mother to offspring through 
factors including immunoglobulin, complement factors, lysozymes, protease inhibitors, 
lectins, and serine protease like molecules.  Maternally derived IgM persists for a limited 
time, exhausts around completion of the yolk absorption process, and completely 
disappears during larval stages.  Maternal transfer of immunity depends on the health and 
immune status of the brood fish.  For fish embryos and larvae to survive against 
microbial infection maternal immunity is required.  The mechanism of IgM uptake and 
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storage within eggs is unknown.  Maternally transferred IgM provide defense against 
infectious agents (Swain and Nayak, 2009).  Thus, based on the fact that IgM must be 
transferred from mother to egg during spawning, it was hypothesized that the female 
immune system (in terms of the levels of secreted and membrane IgM) would look 
different from the male immune system at that time.     
 It is well known that sex steroids have an effect on the immune system.  Thus, the 
hypothesis that the male and female immune systems would look different during 
spawning was because different hormones have differing effects on the immune system 
and males and females produce different hormones.  In O. mykiss estrogen is shown to 
stimulate the proliferation of PBL in vitro.  The rise of sex hormones such as estradiol-
17β, oestradiol, testosterone, 11-ketotestosterone and androstenedione can suppress the 
plasma IgM and IgM secreting cells during spawning period leading to 
immunosuppressive condition in fish (Harris and Bird, 2000 and Swain and Nayak, 
2009).  In mammals, androgens are associated with male and estrogens with female 
reproductive function.  In fish, testosterone and androstenedione are major products in 
female fish.  In the teleost testis, 11-ketotestosterone of 11b-OH testosterone are the most 
potent androgens (Harris and Bird, 2000).  Based on these data, it appears that the male 
immune system, and IgM levels, are more strongly affected by sex steroids.  Both male 
and female sexually mature salmonids have immune deficiencies during spawning and 
are subject to increased ectoparasitic infestations (Harris and Bird, 2000).  Thus, based on 
this hypothesis presented here, it would follow that the immune systems of males and 
females, while both deficient during spawning, would be differently affected by the 
hormones that they are secreting at this time.   
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 Male and female samples did not appear to have strong differences in IgM 
relative expression levels nor in Pax5 relative expression levels in this study.  More 
samples would need to be collected and analyzed in order to strengthen this conclusion.   
Pax Changes During Humoral Immune Response 
 Our data support the model that the level of Pax5Δ2 (relative to Pax5FL) 
increases as the level of secreted IgM (relative to membrane IgM) increases in 
Oncorhyncus immune tissues.  This pattern of expression was strongly supported by 
freshly isolated samples from O. Mykiss that had not experienced any form of laboratory 
induced stress or immune system activation.  These samples, from fish who were kept as 
healthy as possible in the laboratory, showed a strongly positive linear correlation (R2 = 
.99) between secreted IgM and Pax5Δ2 levels in the spleen.  PBL samples also showed a 
positive linear correlation, but with a less strong coefficient of linearity (R2 = 0.59).  Our 
LPS activated O. mykiss samples also weakly exhibited a positive correlation between 
secreted IgM and Pax5Δ2.  The Pax5Δ2 expression relative to Pax5FL appears to 
increase as the relative levels of secreted IgM increase both when the immune system is 
not activated and when it is activated.  From the study of spawning O. nerka, our data 
indicate that as the immune system activates in order to fight pathogens encountered 
during spawning, there is also an increase in relative levels of secreted IgM and this 
increase correlates with an increase in the relative levels of Pax5Δ2.  These results 
suggest that Pax5Δ2 may be involved in the alternative splicing of the IgM gene to switch 
from membrane to secreted forms of the protein. 
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 However, it has been shown by others that LPS-induced Blimp1 plays a direct 
role in the switch from membrane to sercreted IgM (Kallies and Nutt, 2007).  Blimp1 
suppresses Pax5 expression upon B cell activation, but in this present study an increase in 
the levels of Pax5Δ2 was seen as more secreted IgM was produced.  It is possible that as 
B cells become more activated, they start making more Pax5Δ2, which acts as a 
“temporary, dominant negative” form of the Pax5FL protein as a means to lower Pax5 
function, but not have it fully repressed.  Ultimately, as a B cell becomes a plasma cell, 
Pax5 levels will become completely repressed.  In-between states of terminal B cell 
differentiation may use alternative splicing of Pax5 to regulate its own function and thus 
allow proper expression level of the transcription factor until the plasma cell stage where 
Pax5 is no longer needed. 
Directions for Future Studies 
 This study provided support for the idea that Pax5Δ2 isoform expression relative 
to Pax5FL expression increases as the level of secreted IgM increases relative to the level 
of membrane IgM.  The data generated from the anterior and posterior kidney were 
difficult to interpret based on the large variety of cell type found in these tissues.  Both 
tissues are expected to contain developing B cells (which have high levels of Pax5), and 
several antibody-secreting cell types, including plasmablasts and plasma cells (Zwollo et 
al., 2010).  Therefore, qPCR is not the preferred method of analysis for these tissues, 
Flow Cytometric analysis of all the different stages of B-cell found in the spawning fish 
would enable us to further understand the data obtained from these tissues.    
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Additionally, it would be very interesting to perform a functional study of the 
Pax5Δ2 isoform in these samples.  A functional study would determine if our hypothesis 
that Pax5Δ2 is acting as a co-repressor of Pax5FL and allowing activated mature B-cells 
to move toward becoming plasma cells that secrete IgM is correct.  Techniques such as 
transient transfections, eletrophoretic mobility shift assays, and many others would be 
used for functional analysis of the Pax5Δ2 isoform.  This research is significant because 
Pax5 has been implicated in playing a role in multiple forms of B-cell lymphomas as well 
as other forms of cancer in humans (Decker et al., 2008).  Therefore, this research could 
provide important insights into the role that Pax5Δ2 plays in oncogenesis or in the 
maintenance of the oncogenic phenotype.  Additionally, a functional analysis could 
provide insight on how Pax5Δ2 functions during B-cell maturation and the switch from 
plasmablast to IgM secreting plasma cell.  Determining the expression pattern and 
function of Pax5 isoforms is an important first step in fully characterizing the B-cell.  
 To strengthen the real-time PCR results, a number of experiments need to be 
conducted.  First, we will need to repeat in vitro LPS activation experiments in O.mykiss, 
or even better, O. nerka, to obtain more consistent results.  Our current data from four 
LPS activations were not consistent enough to fully illustrate what is happening during 
activation.  From the LPS data shown in the results section, it is apparent that there is a 
positive correlation between secreted IgM levels and Pax5Δ2; however, the cells in this 
study experienced a massive die-off between day 0 and day 2, and then never appeared to 
become strongly activated.  Because this part of the study is being used as an in vitro 
control, it is very important that this control be repeated and results more strongly 
supported.  Additionally, we need to obtain O. nerka samples that are not from spawning 
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fish to use as a proper reference sample, and also to understand and appreciate better the 
changes that occur during spawning.  Although unlikely based on the highly conserved 
nature of the Pax5 gene, the O. mykiss samples could potentially differ significantly from 
the O. nerka.  Thus, using the rainbow trout as a reference sample may be affecting the 
results.  Finally, more samples need to be analyzed.  Currently, the number of samples 
analyzed for this experiment from each location is very small which could lead to skewed 
results.  Collecting and analyzing at least 10-15 total animals per site, will help to 
standardize our relative expression levels and will strengthen our results. 
 Season and environment have also been shown to affect the immune system of 
brood fish.  Thus, measurement of the water temperature, pH, and O2 content where 
samples are being collected would also be interesting variables to include.  It is 
established that seasonal cycles affect several biological activities in fish (summarized in 
Swain and Nayak, 2009).  Among the environmental factors, temperature is known to 
affect the fish immune system.  IgM levels are reduced when the temperature is very low.  
Conversely, serum protein levels, including IgM, rise during the summer in several 
species of fish (Swain and Nayak, 2009).  From these data, it is apparent that water 
temperature and other variables can strongly affect the immune system of fish, thus it 
would be interesting to include water quality variables in our study.   
 This project has provided insight into the relationship between the alternative 
splicing of Pax5 and an immune response in spawning fish.  More work needs to be done 
to strengthen the results of this study, but this study has optimized the assays needed to 
analyze future samples and thus has laid the framework for the future study of this 
system.
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Attachment 1 
RNA Quality 
 The quality of RNA used in a qPCR reaction needs to be very high because the 
accuracy of gene expression studies is influenced by the quantity and quality of the 
starting RNA.  Low quality RNA can strongly compromise the results of downstream 
applications (Fleige and Pflaff, 2006).  RNA samples that contain genomic DNA or are 
degraded will cause the SYBR green to bind non-specifically and can drastically affect 
results.  The first major obstacle in for this project was obtaining high quality RNA.  
High quality RNA is defined as RNA that is free of protein (260/280nm greater than 1.8), 
free of genomic DNA, undegraded (28S:18S ratio should be between 1.8 and 2.0), free of 
enzymatic inhibitors, free of substances which complex with reaction co-factors (Mg2+ or 
Mn2+), and free of nucleases for storage (Fleige and Pfaffl, 2006).  Tissues such as the 
spleen and anterior kidney contain a large number of enzymes, making the process of 
extracting RNA from these tissues very difficult.  Before starting the real-time PCR assay 
optimization, a RNA extraction protocol needs to be optimized in order to obtain a 
sufficient quantity of high quality RNA from the precious samples collected in Alaska.  
The Trizol protocol described in the Methods allowed us to obtain high quality RNA 
based on spectrophotometric analysis using the NanoDrop.   
 In this study, the RNA from the 2010 samples is of slightly higher quality (based 
on 260/280 ratios greater than 1.8) than the RNA from the 2009 fish collection.  After 
discovering the difficult nature of RNA extraction from these tissues, more precaution 
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was taken when storing samples from the 2010 collection.  These precautionary steps 
included slicing the tissue to allow RNAlater access to more parts of the tissue and 
placing the sample on ice immediately to slow enzymatic degradation of the RNA.   
Importance of Careful Assay Design 
 PCR is the most sensitive method available to discriminate between closely 
related mRNAs.  Real-time PCR is highly sensitive and is able to quantify a range of up 
to seven orders of magnitude (Jain et al., 2006).  Thus, we chose real-time PCR as our 
method of choice for studying differential expression of Pax5 isoforms in B-cells.  In 
order for this experiment to produce reliable data, the efficiency of the real-time PCR 
design was critical.  The use of SYBR green for the real-time PCR required extensive 
optimization to ensure that the fluorescence measured was the result of specific product 
and not non-specific binding (Dorak, 2011).  Primers were carefully designed to: 1) 
anneal specifically to the desired sequence, 2) to produce only one product, and 3) to 
avoid SYBR green dye binding to non-target, double-stranded DNA.  Additionally, 
comparative real-time PCR results must be normalized with a reference or housekeeping 
gene.  This gene should remain constant between cells of different tissues and under 
different environmental conditions.  If the expression of this gene changes between 
tissues or due to differing environmental changes, it could lead to erroneous results (Jain 
et al., 2006).  For this experiment, tubulin was chosen as the internal control for gene 
expression analysis because of its uniform expression.  Thus, all calculations in this study 
were normalized to the level of tubulin found in each sample.   
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 We used melt curve analysis to prove that the assay was performing optimally 
during each real-time run.  During real-time PCR the instrument monitors both DNA 
synthesis as well as the melting point of the product at the end of the amplification 
reactions.  The melting temperature depends on both the length and base composition of 
the DNA double helix.  An assay is running optimally when all PCR products for a 
particular primer pair have the same melting temperature.  Primer-dimer artifacts give a 
peak with a lower melting temperature due to the short DNA sequence (Hunt, 2006).   
The Use of the ΔΔCT Method for qPCR Analysis  
 Data from real-time, quantitative PCR experiments can be analyzed via absolute 
quantification and relative quantification.  Relative quantification relates the relative PCR 
signal of the target transcript to that of a control (sample at day 0, or O. mykiss sample in 
this study).  In this study we used relative quantification via the ΔΔCT method.  The 
ΔΔCT method is an effective method for analyzing relative changes in gene expression 
from real-time PCR studies (Livak and Schmittgen, 2001).  For the ΔΔCT method to be 
valid, a validation experiment must be performed to verify that the target and reference 
reaction efficiencies are similar (Livak and Schmittgen, 2001).  The validation 
experiment was performed by making a series of dilutions of primer and verifying that 
they have similar efficiency (see Validation Experiment in Results).  The internal control 
gene and reference samples were chosen carefully because the values generated by these 
samples will be used as a calibrator for the ΔΔCT calculations (Livak and Schmittgen, 
2001).  Choosing a reference sample was difficult in this study because it is very difficult 
to obtain samples from non-spawning, adult O. nerka, which reside in the open ocean.  
Thus, O. mykiss samples from laboratory tanks were used to model the 
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secreted/membrane IgM and Pax5 transcript levels that may be found in O. nerka 
samples before beginning their journey to the spawning grounds.  Once these important 
variables had been chosen and measured, data were analyzed using the ΔΔCT  method 
(see Methods for Equations).  
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Appendix 
O. mykiss Spleen LPS Data
 
 
Figure 14A: Fold change secreted IgM 
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Figure 14B: Fold change membrane IgM 
 
 
Figure 14C: Fold change Pax5FL 
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Figure 14D:  Fold change Pax5Δ2 
 
 
Figure 14E: Fold change secreted and membrane IgM 
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Figure 14F: Ratio of Sec/Mem IgM  
 
 
Figure 14G: Fold change Pax5FL and Pax5Δ2. 
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Figure 14H: Ratio of Pax5Δ2/Pax5FL Values for Pax5Δ2 are very low. 
 
 
Figure 14I: Ratio of Pax5FL/ Pax5Δ2  
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Figure 14J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5Δ2/Pax5FL fold changes. 
O. mykiss Blood LPS Data 
 
Figure 15A: Fold change secreted IgM 
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Figure 15B: Fold change membrane IgM 
 
 
Figure 15C: Fold change Pax5FL 
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Figure 15D:  Fold change Pax5Δ2 
 
Figure 15E: Fold change secreted and membrane IgM. 
 
Figure 15F: Ratio of Sec/Mem IgM  
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Figure 15G:  Fold Change Pax5FL and Pax5Δ2. 
 
 
Figure 15H: Ratio of Pax5Δ2/Pax5FL  
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Figure 15I: Ratio of Pax5FL/Pax5Δ2  
 
Figure 15J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5Δ2/Pax5FL fold changes. 
Spleen 2009 Data 
 
Figure 16A: Fold change secreted IgM 
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Figure 16B: Fold change membrane IgM 
 
Figure 16C: Fold change Pax5FL 
 
Figure 16D:  Fold change Pax5Δ2.  * SPL 54 and SPL 69 removed due to exceptionally 
high fold change values.   
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Figure 16E: Fold change secreted and membrane IgM. 
 
Figure 16F: Ratio of Sec/Mem IgM  
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Figure 16G: Fold change Pax5FL and Pax5Δ2 
 
Figure 16H: Ratio of delta2/FL  
 
Figure 16I: Ratio of Pax5FL/Pax5Δ2  
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Figure 16J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5FL/Pax5Δ2 fold changes. 
Anterior Kidney 2009 Data 
 
Figure 17A: Fold change secreted IgM 
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Figure 17B: Fold change membrane IgM 
 
Figure 17C: Fold change Pax5FL 
 
Figure 17D:  Fold change Pax5Δ2 
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Figure 17E: Fold change secreted and membrane IgM 
 
Figure 17F: Ratio of Sec/Mem IgM  
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Figure 17G: Fold change Pax5FL and Pax5Δ2 
 
Figure 17H: Ratio of Pax5Δ2/Pax5FL  
 
Figure 17I: Ratio of Pax5FL/Pax5Δ2  
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Figure 17J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5FL/Pax5Δ2 fold changes. 
Posterior Kidney 2009 Data 
 
Figure 18A: Fold Change Secreted IgM.   
 
Figure 18B: Fold change membrane IgM.   
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Figure 18C: Fold change Pax5FL.   
 
Figure 18D:  Fold change Pax5Δ2.  * Sample PK 68 removed because the fold change 
value was 22.41 which made the other samples appear to have no Pax5Δ2. 
 
Figure 18E: Fold change for Sec and Mem IgM together.   
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Figure 18F: Ratio of Sec/Mem IgM.   
 
Figure 18G:  Fold Change Pax5FL and Pax5Δ2.  Sample 68 was left out of this graph 
because the fold change value was very high and made the other samples appear to have 
negligible amounts of Pax5.   
 
Figure 18H: Ratio of Pax5Δ2/Pax5FL.   
0 
5 
10 
15 
20 
25 
Ref   PK 51   PK 52   PK 53   PK 54   PK 55   PK 56   PK 62   PK 64   PK 66   PK 68   PK 69 
PK 2009 Ra4o of Sec/Mem IgM 
0 
0.5 
1 
1.5 
Ref   PK 51   PK 52   PK 53   PK 54   PK 55   PK 56   PK 62   PK 64   PK 66   PK 69 
PK 2009 Pax5 No PK68 
PaxFL 
Paxde2 
0 
20 
40 
60 
Ref   PK 51   PK 52   PK 53   PK 54   PK 55   PK 56   PK 62   PK 64   PK 66   PK 68   PK 69 
Ra4o of Pax5Δ2/Pax5FL 
84 
 
 
 
Figure 18I: Ratio of Pax5FL/Pax5Δ2.   
 
Figure 18J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5FL/Pax5Δ2 fold changes (outliers have been removed).   
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Figure 19A: Fold change secreted IgM 
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Figure 19B: Fold change membrane IgM 
 
Figure 19C: Fold change Pax5FL 
 
Figure 19D:  Fold change Pax5Δ2 
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Figure 19E: Fold change secreted and membrane IgM 
 
Figure 19F: Ratio of Sec/Mem IgM  
 
Figure 19G: Fold change Pax5FL and Pax5Δ 
0 
5000 
10000 
15000 
20000 
25000 
30000 
35000 
Ref  PBL 51  PBL 52  PBL 53  PBL 54  PBL 55  PBL 56  PBL 62  PBL 64  PBL 66  PBL 68  PBL 69 
PBL 2009 Sec and Membrane  
Fold Change 
Membrane 
Fold Change 
Secreted 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
Ref   PBL 51  PBL 52  PBL 53  PBL 54  PBL 55  PBL 56  PBL 62  PBL 64  PBL 66  PBL 68  PBL 69 
PBL 2009 Ra4o of Sec/Mem  
0 
1000 
2000 
3000 
4000 
5000 
6000 
Ref   PBL 51  PBL 52  PBL 53  PBL 54  PBL 55  PBL 56  PBL 62  PBL 64  PBL 66  PBL 68  PBL 69 
PBL 2009 Pax5FL and Pax5Δ2  
Fold Change 
PaxFL 
Fold Change 
de2 
87 
 
 
 
Figure 19H: Ratio of Pax5Δ2/Pax5FL  
 
Figure 19I: Ratio of Pax5FL/Pax5Δ2  
 
Figure 19J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5FL/Pax5Δ2 fold changes. 
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Spleen 2010 Data 
 
Figure 20A: Fold change secreted IgM 
 
Figure 20B: Fold change membrane IgM 
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Figure 20C: Fold change Pax5FL 
 
Figure 20D:  Fold change Pax5Δ2 
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Figure 20E: Fold change secreted and membrane IgM 
 
Figure 20F: Ratio of Sec/Mem IgM  
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Figure 20G: Fold change Pax5FL and Pax5Δ2 
 
Figure 20H: Ratio of Pax5Δ2/Pax5FL  
 
Figure 20I: Ratio of Pax5FL/Pax5Δ2  
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Figure 20J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5FL/Pax5Δ2 fold changes. 
Anterior Kidney 2010 Data 
 
Figure 21A: Fold change secreted IgM 
 
Figure 21B: Fold change membrane IgM 
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Figure 21C: Fold change Pax5FL 
 
Figure 21D:  Fold change Pax5Δ2 
 
Figure 21E: Fold change secreted and membrane IgM. 
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Figure 21F: Ratio of Sec/Mem IgM  
 
Figure 21G: Fold change Pax5FL and Pax5Δ2 
 
Figure 21H: Ratio of Pax5Δ2/Pax5FL  
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Figure 21I: Ratio of Pax5FL/Pax5Δ2  
 
Figure 21J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5FL/Pax5Δ2 fold changes. 
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Posterior Kidney 2010 Data
 
Figure 22A: Fold change secreted IgM.   
 
Figure 22B: Fold change membrane IgM.  *Samples 111 and 112 have been removed 
from the analysis due to very high membrane IgM levels. 
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Figure 22C: Fold change Pax5FL.  
 
Figure 22D:  Fold change Pax5Δ2.   
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Figure 22E:  Fold change secreted and membrane IgM together.  *Samples 111 and 112 
have been removed due to extremely high membrane IgM values. 
 
Figure 22F: Ratio of Sec/Mem IgM.   
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Figure 22G:  Fold change Pax5FL and Pax5Δ2 together.   
 
Figure 22H: Ratio of Pax5Δ2/Pax5FL.   
 
Figure 22I: Ratio of Pax5FL/Pax5Δ2.   
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Figure 22J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5FL/Pax5Δ2 fold changes.   
Blood 2010 Data 
 The PBL 2010 yielded very poor quality RNA and thus only five samples were 
seen as fit to use in qPCR.   
 
Figure 23A: Fold change secreted IgM 
 
Figure 23B: Fold change membrane IgM 
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Figure 23C: Fold change Pax5FL 
 
Figure 23D:  Fold change Pax5Δ2 
 
Figure 23E: Fold change secreted and membrane IgM 
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Figure 23F: Ratio of Sec/Mem IgM  
 
Figure 23G: Fold change Pax5FL and Pax5Δ2 
 
Figure 23H: Ratio of Pax5Δ2/Pax5FL  
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Figure 23I: Ratio of Pax5FL/Pax5Δ2  
 
Figure 23J:  Scatterplot comparing the Ratio of Sec/Mem IgM Fold Changes with the 
Ratio of Pax5FL/Pax52 fold changes.   
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Figure 24: Ratio of Sec/Mem IgM for male and female samples.   
 
 
Figure 25: Ratio of Pax5Δ2/Pax5FL for male and female samples. 
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Figure 26: Ratio of Sec/Mem IgM for male and female samples.   
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Figure 27: Ratio of Pax5Δ2/Pax5FL for male and female samples. 
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Figure 28: Ratio of Sec/Mem IgM for male and female samples.   
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Figure 29: Ratio of Pax5Δ2/Pax5FL for male and female samples. 
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Figure 30: Ratio of Sec/Mem IgM for male and female samples.   
 
 
Figure 31: Ratio of Pax5Δ2/Pax5FL for male and female samples. 
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